BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 1830745)

  • 41. Role of vascular endothelial cells in the allograft response.
    Brindle NP
    Eye (Lond); 1995; 9 ( Pt 2)():167-72. PubMed ID: 7556712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection.
    Shreeniwas R; Schulman LL; Narasimhan M; McGregor CC; Marboe CC
    Chest; 1996 Nov; 110(5):1143-9. PubMed ID: 8915211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunopathology of cardiac transplant rejection.
    Duquesnoy RJ; Demetris AJ
    Curr Opin Cardiol; 1995 Mar; 10(2):193-206. PubMed ID: 7787286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Granzymes and perforin in solid organ transplant rejection.
    Choy JC
    Cell Death Differ; 2010 Apr; 17(4):567-76. PubMed ID: 19876069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial activation and cytokine expression in human acute cardiac allograft rejection.
    Salom RN; Maguire JA; Hancock WW
    Pathology; 1998 Feb; 30(1):24-9. PubMed ID: 9534204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SK&F 105685 suppresses allogeneically induced mononuclear and endothelial cell activation and cytokine production and prolongs rat cardiac allograft survival.
    Hancock WW; Schmidbauer G; Badger AM; Kupiec-Weglinski JW
    Transplant Proc; 1992 Feb; 24(1):231-2. PubMed ID: 1539260
    [No Abstract]   [Full Text] [Related]  

  • 47. Usefulness of T-cell phenotype characterization in endomyocardial biopsy fragments from human cardiac allografts.
    Higuchi ML; de Assis RV; Sambiase NV; Reis MM; Kalil J; Bocchi E; Fiorelli A; Stolf N; Bellotti G; Pileggi F
    J Heart Lung Transplant; 1991; 10(2):235-42. PubMed ID: 1674430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transplantation and cytokines.
    Bumgardner GL; Orosz CG
    Semin Liver Dis; 1999; 19(2):189-204. PubMed ID: 10422200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Humoral autoimmunity and transplant vasculopathy: when allo is not enough.
    Win TS; Pettigrew GJ
    Transplantation; 2010 Jul; 90(2):113-20. PubMed ID: 20531074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Immunological Basis of Liver Allograft Rejection.
    Ronca V; Wootton G; Milani C; Cain O
    Front Immunol; 2020; 11():2155. PubMed ID: 32983177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell receptor repertoires within liver allografts are different to those in the peripheral blood.
    Mederacke YS; Nienen M; Jarek M; Geffers R; Hupa-Breier K; Babel N; Reinke P; Mederacke I; Vondran FWR; Jonigk D; Wedemeyer H; Jaeckel E
    J Hepatol; 2021 May; 74(5):1167-1175. PubMed ID: 33347951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokines as mediators of vascular pathology.
    Libby P; Clinton SK
    Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S47-53. PubMed ID: 1340529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cells, cytokines, adhesion molecules, and humoral responses in a rat model of chronic renal allograft rejection.
    Hancock WW; Whitley WD; Baldwin WM; Tilney NL
    Transplant Proc; 1992 Oct; 24(5):2315-6. PubMed ID: 1413075
    [No Abstract]   [Full Text] [Related]  

  • 54. Increased frequency of regulatory T cells and selection of highly potent CD62L+ cells during treatment of human lung transplant recipients with rapamycin.
    Lange CM; Tran TY; Farnik H; Jungblut S; Born T; Wagner TO; Hirche TO
    Transpl Int; 2010 Mar; 23(3):266-76. PubMed ID: 19804585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The innate natural killer cells in transplant rejection and tolerance induction.
    Kroemer A; Edtinger K; Li XC
    Curr Opin Organ Transplant; 2008 Aug; 13(4):339-43. PubMed ID: 18685327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Inflammation and rejection].
    Chatenoud L; Bach JF
    Nephrologie; 1990; 11(4):189-93. PubMed ID: 1706077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological function of the endothelial cell within the setting of organ transplantation.
    Taflin C; Charron D; Glotz D; Mooney N
    Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A plan to suppress or prevent the immune rejection of allografted organs.
    Jacoby M; Brock M
    Lymphology; 1992 Mar; 25(1):42-6; discussion 46-7. PubMed ID: 1533258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
    Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; GrinyĆ³ JM; Bestard O
    PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presence of CD4, CD8 double-negative and T-cell receptor-gamma-delta-positive T cells in lymphocyte cultures propagated from coronary arteries from heart transplant patients with graft coronary disease.
    Duquesnoy RJ; Kaufman C; Zerbe TR; Woan MC; Zeevi A
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S83-6. PubMed ID: 1535793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.